Corcept Therapeutics
CORT
#2406
Rank
C$10.83 B
Marketcap
C$99.02
Share price
-5.10%
Change (1 day)
-5.97%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of November 2026 (TTM): 7.86

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.7. At the end of 2026 the company had a P/S ratio of 13.0.

P/S ratio history for Corcept Therapeutics from 2007 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202613.0146.63%
20255.29-35.09%
20248.1417.34%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.85-12.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.27-32.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.59-67.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
14.7 87.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.29-32.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.57-67.30%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
3.23-58.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
1.96-75.08%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.07-60.91%๐Ÿ‡บ๐Ÿ‡ธ USA